We are live on
!
Find out more
SCM
SCS Capital Management Portfolio holdings
AUM
$9.44B
1-Year Est. Return
18.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.2%
1 Year Est. Return
+18.1%
3 Year Est. Return
+43.85%
5 Year Est. Return
+38.42%
10 Year Est. Return
+105.54%
AUM
$9.02B
AUM Growth
+$1.16B
(+15%)
Cap. Flow
+$465M
Cap. Flow
% of AUM
5.16%
Top 10 Holdings %
Top 10 Hldgs %
50.19%
Holding
567
New
54
Increased
230
Reduced
170
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$57.7M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$39.8M |
| 3 |
Microsoft
MSFT
|
+$21.9M |
| 4 |
RTX Corp
RTX
|
+$19.9M |
| 5 |
JPMorgan Chase
JPM
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacer US Cash Cows 100 ETF
COWZ
|
+$23.6M |
| 2 |
LPL Financial
LPLA
|
+$19.7M |
| 3 |
XPEL
XPEL
|
+$16.8M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$14.8M |
| 5 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.46% |
| 2 | Financials | 3.09% |
| 3 | Healthcare | 2.24% |
| 4 | Industrials | 1.55% |
| 5 | Consumer Discretionary | 1.49% |
Similar funds
RCMNY
RCM
SIM
NPT
AC
PVI
WPL
BAMF
SCS Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, SCS Capital Management held 567 positions worth $9.02B, up 15% from $7.86B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
SCS Capital Management deployed $465M of net new capital in Q2 2025, opening 54 new positions and adding to 230 existing holdings. Its largest new stake was Ventas: 216,900 shares worth $13.8M.
By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 2.3% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Pacer US Cash Cows 100 ETF, an estimated $23.6M trimmed.
- SCS Capital Management's largest Q2 2025 buy was Ventas: 216,900 shares worth $13.8M.
- SCS Capital Management added most to iShares MSCI USA Quality Factor ETF in Q2 2025, an estimated $57.7M increase.
- SCS Capital Management's biggest Q2 2025 reduction was Pacer US Cash Cows 100 ETF, cutting an estimated $23.6M.
- SCS Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $9.6M.
- SCS Capital Management's ten largest holdings make up 50% of its $9.02B portfolio in Q2 2025.
- SCS Capital Management opened 54 new positions and closed 18 in Q2 2025.
- SCS Capital Management's portfolio value rose 15% quarter-over-quarter to $9.02B.
Based on SCS Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.